Florida Department of HealthEPI UPDATE

A weekly publication by the Bureau of Epidemiology

February 16, 2001

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Jason Glisson, BS, Epi Editorial Assistant

Bureau of Epidemiology Frequent Contributors:

Steven Wiersma, MD, MPH,

Deputy State Epidemiologist

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH,

SE Florida

Roger Sanderson, RN, MA,

SW Florida

Carina Blackmore, MS Vet. Med., PhD,

NE Florida Carina Blackmore, MS Vet. Med., PhD,

Zuber Mulla, MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

The Department of Health has a home on the World Wide Web at http://www.doh.state.fl.us

In this issue:

1. Merlin System- User Update

2. Influenza Surveillance Update

3. Weekly Disease Table (Week 6)


 

1. Merlin System- User Update

Kathryn Snavely, MPH, Reporting Systems Manager

The Merlin technical staff published another Merlin version today--version 1.09. These changes were based primarily based on recommended by county health department Merlin users. We thank them for their input. The documentation for version 1.09 is attached.

Changes To Existing Functions

New selections on the Basic Case Information screen for Reporter Type include: Self, Parent, Animal Control, and Other.

The ICD9 code for Ehrlichiosis, Human has been replaced with two codes, one for Ehrlichiosis, Human Monocytic and one for Ehrlichiosis, Human Granulocytic.

The lab results drop down menu has been changed to include Indeterminate; and Reactive has been removed. Please use the result Positive in the place of Reactive.

There are also many new hepatitis specific test types in the drop down menu on the lab result screens. They are the same test types available on the panel page.

New contact types were added to the Epi-Link Relationship screen to include Personal Contact, Common Food, Undetermined, Environmental, and HC Provider.

Lab number will now be printed on the screen for both unattached and case related lab results.

"Needs DOH Review" has now been changed to "Needs CRF" to clarify the status and now appears on both the data entry and supervisor task lists.

Delivery date for the pregnancy question on the hepatitis extended data screen now allows future dates.

Improvements To Merlin

There is now an "Investigator" field on the Basic Case Information screen. This field is for your internal case management. The drop down menu shows all the user ID’s for your county and will be visible only to your county Merlin users. We are working on building reports and incorporating this field value into the Task List.

Please let me know if you have any questions or email the Merlin Helpdesk.

-Kathryn Snavely
S/C 205-4444, X2447

Merlin system user update word document

 

2. Influenza Surveillance Update

Carina Blackmore, MS, Vet. Med., PhD, NE Florida

(Week ending February 3, 2001-Week 5)

Florida: Florida is one of 13 states still reporting low levels of influenza activity. Overall, two percent of 14,870 patients seeking care by reporting physicians in the influenza sentinel surveillance network met the case definition for ILI during week 5. Influenza-like illness activity was detected statewide from Escambia to Miami Dade. Higher flu activity than expected for this time of year (>3%) was reported by physicians in Alachua, Escambia, Pasco and Polk counties. Eight+ isolates of influenza were reported to our laboratory database this week: influenza A (H1N1) was isolated from patients in Charlotte (1), Duval (3), and Leon (1) counties. Influenza A was also detected in specimens collected from a patient in Palm Beach County. Flu B was reported from Alachua (1), Duval (3), Hillsborough (1) and Leon (2) counties. Since October 1,115 influenza isolations have been reported to the state health office: 40 influenza A (H1N1) isolates from Broward, Charlotte, Dade, Duval, Escambia, Hillsborough, Indian River, Lake, Leon, Nassau, Orange and Polk counties, one influenza A (H3N2) from Duval county, 15 untyped influenza A isolates from Alachua, Clay, Columbia, Hillsborough, Orange, Palm Beach and Pinellas counties) and 59 influenza B isolates from Brevard, Broward, Charlotte, Clay, Duval, Hillsborough, Indian River, Leon, Levy, Orange, Palm Beach, Santa Rosa, Seminole and Volusia counties.

National report: Eleven (Colorado, Connecticut, Minnesota, Mississippi, North Carolina, Oklahoma, Rhode Island, Tennessee, Utah, Virginia, and Washington) state and territorial health departments reported widespread and 26 states reported regional activity during week 5. WHO and NREVSS laboratories reported 1,459 specimens tested for influenza viruses, of which 323 (22%) were positive. Sixty-nine (21%) were influenza A (H1N1) viruses, 167 (52%) were unsubtyped influenza A viruses, and 87 (27%) were influenza B viruses. The highest yield in recent weeks (week 3-5) was seen in from patients in the South Atlantic region (which includes Florida) where 35% tested positive for flu.

The 2000-2001 flu vaccine induces reactive antibodies against all 247virus strains that have been antigenically characterized at CDC this year.

During week 5, the percentage of all deaths due to P&I as reported by the vital statistics offices of 122 U.S. cities was 7.6%, which is below the epidemic threshold of 8.7%

Four percent of patient visits to U.S. sentinel physicians were due to influenza-like illness (ILI). The percentage of patient visits for ILI was above baseline levels (3%) in 8 of 9 surveillance regions. Influenza activity was within baseline levels in the East North Central Region (Illinois, Indiana, Ohio, Michigan and Wisconsin).

Respiratory syncytial virus (RSV) activity is declining across the state. Between 13.0 and 25.2% of tested specimens were positive for RSV this week. Twelve Florida hospital laboratories participate in this program.

flu report excel doc

3. Weekly Disease Table (Week 6)

DISEASE

1998 TO
CURRENT
WEEK #

1999 TO
CURRENT
WEEK #

2000 TO
CURRENT
WEEK #

3 YEAR
AVERAGE
TO CURRENT
WEEK #

2000
TOTAL
CASES

2001 TO
CURRENT
WEEK #

Animal Rabies

20

18

11

16.3333

162

14

Anthrax

0

0

0

0

0

0

Botulism, foodborne

0

0

0

0

0

0

Botulism, infant

0

0

0

0

0

0

Botulism, wound

0

0

0

0

0

0

Botulism, other

0

0

0

0

0

0

Brucellosis

0

0

0

0

2

0

Campylobacteriosis

46

56

40

47.3333

1015

37

Ciguatera

0

0

0

0

14

0

Cryptosporidiosis

10

2

6

6

175

8

Cyclosporiasis

0

0

0

0

9

8

Dengue Fever

0

0

0

0

5

0

Diphtheria

0

0

0

0

0

0

Ehrlichiosis, human

0

0

0

0

0

0

Encephalitis, chickenpox

0

0

0

0

0

0

Encephalitis, Eastern Equine

0

0

0

0

0

0

Encephalitis, herpes

2

0

0

0.6667

5

0

Encephalitis, influenza

0

0

0

0

1

0

Encephalitis, measles

0

0

0

0

0

0

Encephalitis, mumps

0

0

0

0

0

0

Encephalitis, other

0

0

0

0

8

0

Encephalitis, St. Louis

0

0

0

0

0

0

Encephalitis, Venezuelan

0

0

0

0

0

0

Encephalitis, Western Equine

0

0

0

0

0

0

Escherichia Coli 0157:H7

2

3

2

2.3333

93

1

Escherichia Coli, other

0

1

1

0.6667

14

1

Giardiasis

80

61

34

58.3333

1406

20

H. Influenzae Cellulitis

1

0

0

0.3333

1

0

H. Influenzae Epiglottitis

0

0

0

0

1

0

H. Influenzae Meningitis

2

2

0

1.3333

12

2

H. Influenzae Pneumonia

1

1

0

0.6667

8

1

H. Influenzae Prim.Bacteremia

5

2

2

3

52

8

H. Influenzae Septic Arthritis

0

0

0

0

1

0

Hantaviris Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

0

0

0

0

16

0

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

37

33

30

33.3333

577

25

Hepatitis B

12

14

20

15.3333

501

13

Hepatitis B (+HbsAg in pregnant women)

NR

1

11

NR

468

10

Hepatitis, Perinatal Hep B

NR

0

0

NR

1

0

Hepatitis C

NR

1

2

NR

20

1

Hepatitis, Non-A, Non-B

5

0

1

2

6

0

Hepatitis, Other, including unspecified

0

0

2

0.6667

7

0

Lead Poisoning

161

136

40

112.3333

954

31

Legionellosis

3

4

6

4.3333

53

1

Leprosy

0

0

0

0

4

0

Leptospirosis

0

0

0

0

2

0

Listeriosis

NR

1

2

NR

32

0

Lyme Disease

0

1

0

0.3333

51

0

Malaria

2

8

0

3.3333

81

1

Measles

1

0

0

0.3333

2

0

Meningitis, Group B Strep

1

2

0

1

21

2

Meningitis, List Monocytogenes

1

0

1

0.6667

7

0

Meningitis, Meningococcal

5

6

3

4.6667

42

7

Meningitis, other

3

3

2

2.6667

106

1

Meningitis, Strep Pneumoniae

17

17

11

15

110

7

Meningococcemia, disseminated

7

7

10

8

82

8

Mercury Poisoning

0

0

0

0

11

0

Mumps

1

0

0

0.3333

4

0

Neurotoxic Shellfish Poisoning

0

0

0

0

0

0

Pertussis

8

2

1

3.6667

48

0

Pesticide-Related Illness and Injury

1

0

1

0.6667

2

0

Plague, Bubonic

0

0

0

0

0

0

Plague, Pneumonic

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

0

0

0

2

0

Q Fever

NR

0

0

NR

0

0

Human Rabies

0

0

0

0

0

0

Rocky Mountain Spotted Fever

0

0

0

0

2

0

Rubella

0

0

0

0

2

0

Rubella, Congenital

0

0

0

0

1

0

Salmonellosis

135

123

83

113.6667

2726

107

Shigellosis

85

81

58

74.6667

1281

42

Smallpox

NR

0

0

NR

0

0

Staphylococcus Aureus (GISA/VISA)

NR

0

0

NR

0

0

Staphylococcus Aureus (GRSA/VRSA)

NR

0

0

NR

0

0

Streptococcal Disease, Invasive Group A

3

6

7

5.3333

148

9

Streptococcus Pneumoniae, Invasive

48

33

89

56.6667

1138

82

Tetanus

0

0

0

0

1

0

Toxoplasmosis

2

0

0

0.6667

12

0

Trichinosis

0

0

0

0

0

0

Tularemia

NR

0

0

NR

0

0

Typhoid Fever

4

2

0

2

12

0

Vibrio Alginolyticus

0

2

1

1

15

0

Vibrio Cholerae Type 01

0

0

0

0

0

0

Vibrio Cholerae Non-01

0

2

0

0.6667

4

0

Vibrio Fluvialis

0

0

0

0

2

0

Vibrio Hollisae

0

0

1

0.3333

3

0

Vibrio Mimicus

0

0

0

0

2

0

Vibrio, other

0

0

0

0

1

0

Vibrio Parahaemolyticus

0

1

1

0.6667

16

0

Vibrio Vulnificus

0

0

0

0

13

0

Yellow Fever

0

0

0

0

0

0